Fresenius Medical Care AG & Co KGaA (FMEG.DE)
* Says expects care coordination businesses to start adding to earnings from 2016
FRANKFURT - German healthcare group Fresenius SE lifted its full-year earnings forecast as its rivals in the U.S. generic infusion drug market grappled with supply shortages longer than expected.
* Expects adj net income growth of 13-16 pct, before forex effects
FRANKFURT, April 29 - Kidney dialysis specialist Fresenius Medical Care (FMC) reported a 2 percent rise in quarterly net profit, meeting expectations, and confirmed its guidance for 2015.
(The following statement was released by the rating agency) LONDON, March 19 (Fitch) Fitch Ratings has revised Fresenius Medical Care AG & Co. KGaA's (FMC) and Fresenius SE & Co. KGaA's (FSE, consolidated 'Fresenius') Outlook to Stable from Positive. Its Long- and Short-term Issuer Default Ratings (IDRs) have been affirmed at 'BB+' and 'B', respectively. Please see below for a detailed list of rating actions. Although Fresenius' business risk profile has improved, with its scale, profitabil
FRANKFURT, Feb 25 - Dialysis provider Fresenius Medical Care is eyeing Europe as a place to take a first step into so-called care coordination businesses outside its main market North America.
FRANKFURT - Kidney dialysis specialist Fresenius Medical Care forecast strong profit growth in 2016 after more modest progress this year while it cuts costs to counter pressures on payments for treatment in the United States and moves into new healthcare services.
* FMC sees forex-adjusted net income growth of 0-5 pct in 2015
FRANKFURT, Feb 25 - German kidney dialysis specialist Fresenius Medical Care (FMC) said net income could be flat this year but would grow again in 2016, as it cuts costs to counter pressure in the United States on reimbursement for dialysis treatments.
FRANKFURT, Jan 19 - German healthcare group Fresenius, the owner of Europe's largest private-sector hospitals chain, received investment-grade status from a ratings agency for the first time, after recent acquisitions have spread its business risks.
Earnings vs. Estimates
Analyst Research Reports
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Fresenius Medical Care - Finlabo Research Equity Report: Fundamental and Technical Analysis and 6 months performance forecast
Provider: Finlabo SIM Spa
Provider: S&P Capital IQ – STARS Reports
Fresenius Medical Care AG & Co KGaA: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.